Company lists · Data refreshed September 2026

Top 14 Neuroscience drug developers based in Australia

RevenueBase identified 34 neuroscience drug developers headquartered in Australia as of September 2026 and tracks 296 professional contacts across them, including 126 with verified work emails. Melbourne is the largest hub.

This list covers neuroscience drug developers headquartered in Australia, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 20, 2026.

Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.

How to read this list HQ checked on every row RevenueBase Smart Search rating on every row Refreshed Sep 20, 2026 86% judged on-target in blind review
34Companies
296Contacts tracked
126Verified emails
Explore this list → Free signup · no credit card · 500 free credits

The 14 largest neuroscience drug developers based in Australia

Ranked by team size
Top 14 of 34 neuroscience drug developers based in Australia, ranked by team size, largest first. Data refreshed Sep 20, 2026. RevenueBase Smart Search rates how each company's information relates to neuroscience drug developers: strong evidence (its own description names it), partial (names part of it), indirect (matched on the rest of its profile rather than the description shown). Click a contact count to view that company's people.
#CompanyRevenueBase Smart SearchHeadquartersEmployeesContacts
1Indirect evidenceMelbourne, AustraliaHQ checked Sep 20, 20261-1021 contacts →

Indirect evidence

“Kinoxis Therapeutics Pty Ltd is a private, Australian-based, clinical-stage biotechnology company developing first-in-class therapeutics to address the escalating demand for safe…”

Source: RevenueBase Database · checked Sep 20, 2026
2Partial evidenceDandenong South, AustraliaHQ checked Sep 20, 202611-5017 contacts →

Partial evidence

“PharmSky Research is a pharmaceutical contract research and drug development organisation in Melbourne, Australia.”

Source: RevenueBase Database · checked Sep 20, 2026
3Indirect evidenceSydney, AustraliaHQ checked Sep 20, 202611-5016 contacts →

Indirect evidence

“Actinogen Medical (ASX:ACW) is an ASX-listed biotechnology company developing a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated brain…”

Source: RevenueBase Database · checked Sep 20, 2026
4Indirect evidenceCamberwell, AustraliaHQ checked Sep 20, 202611-5014 contacts →

Indirect evidence

“Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for six debilitating neurodevelopmental disorders that emerge in early childhood and are characterised by impaired…”

Source: RevenueBase Database · checked Sep 20, 2026
5Strong evidenceLeederville, AustraliaHQ checked Sep 20, 202611-5013 contacts →

Strong evidence

“Emyria Limited is a clinical services and drug development company focused on improving patient outcomes in neuroscience and mental health via a unique business model: Emyria…”

Source: RevenueBase Database · checked Sep 20, 2026
6Strong evidenceCottesloe, AustraliaHQ checked Sep 20, 20261-1011 contacts →

Strong evidence

NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) is an Australian drug development company developing novel peptide-based pharmaceutical products that target a number of…”

Source: RevenueBase Database · checked Sep 20, 2026
7Indirect evidenceSydney, AustraliaHQ checked Sep 20, 202611-5010 contacts →

Indirect evidence

“Southern Neurology is a group neurology practice providing comprehensive clinical neurology, neurophysiology and research services.”

Source: RevenueBase Database · checked Sep 20, 2026
8Indirect evidenceMelbourne, AustraliaHQ checked Sep 20, 20261-109 contacts →

Indirect evidence

“Neurizon Therapeutics Limited (ASX: NUZ), formerly known as PharmAust, is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases.”

Source: RevenueBase Database · checked Sep 20, 2026
9Indirect evidenceNedlands, AustraliaHQ checked Sep 20, 20261-109 contacts →

Indirect evidence

“Argenica Therapeutics(ASX: AGN) is developing novel therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to…”

Source: RevenueBase Database · checked Sep 20, 2026
10Indirect evidenceSydney, AustraliaHQ checked Sep 20, 20261-107 contacts →

Indirect evidence

“Celosia Therapeutics is a privately held pre-clinical stage gene therapy company, developing solutions for neurodegenerative diseases that have limited alternative therapeutic…”

Source: RevenueBase Database · checked Sep 20, 2026
11Indirect evidenceNedlands, AustraliaHQ checked Sep 20, 202611-505 contacts →

Indirect evidence

“Based in Perth, Australia, Patrys, a publicly-listed company on the Australian Securities Exchange (ASX: PAB), is a clinical-stage biotechnology company advancing a dual-platform…”

Source: RevenueBase Database · checked Sep 20, 2026
12Partial evidenceByron Bay, AustraliaHQ checked Sep 20, 202611-502 contacts →

Partial evidence

“Psychedelic Assisted Therapies, Drug Development, Pharmaceutical Trials focussing on mental health”

Source: RevenueBase Database · checked Sep 20, 2026
13Indirect evidenceMelbourne, AustraliaHQ checked Sep 20, 20261-101 contacts →

Indirect evidence

Source: RevenueBase Database · checked Sep 20, 2026
14Partial evidenceNew South Wales, AustraliaHQ checked Sep 20, 20261-101 contacts →

Partial evidence

“We are a specialist neurology and neurosciences and clinical trials research provider.”

Source: RevenueBase Database · checked Sep 20, 2026

Showing 14 of 34 neuroscience drug developers based in Australia

See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 126 reachable decision-makers.

Free signup · no credit card

View the full list →

Neuroscience drug developers based in Australia at a glance

As of Sep 20, 2026
42.6%Verified-email coverage
8.7Average contacts per company
1-10Median size (employees)
32.4%Largest-city concentration · Melbourne
Sep 20, 2026Page data refreshed

Companies by employee count

1-10
20
11-50
10
51-200
2
201-500
1
10001+
1

Email recency for this list is measured worldwide rather than for Australia, so it is reported there. Company counts and contact totals on this page are exact for Australia, over 34 companies.

How this list was built

Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among neuroscience drug developers, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.

Source
The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
What qualifies
Companies headquartered in Australia whose own description of what they do matches “neuroscience drug developers”. Matching reads each company's description, not its industry code or its name.
RevenueBase Smart Search
RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names neuroscience drug developers), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
What we exclude
Companies whose own description does not clearly place them among neuroscience drug developers, and records with no verified work email. Companies headquartered outside Australia are excluded even when they keep an office there.
Match quality
In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
Ranking
Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
Verification
Every listed company carries at least one verified work email, 126 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
Refresh
This page's figures were pulled from the company graph on September 20, 2026. Lists refresh periodically as the graph is re-checked.
Corrections
Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.

Frequently asked

What is RevenueBase Smart Search?

RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names neuroscience drug developers, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.

How many neuroscience drug developers are there based in Australia?

RevenueBase identified 34 neuroscience drug developers headquartered in Australia as of September 2026, matched on each company's own description of what it does rather than its industry code.

What is the largest company on this list?

Kinoxis Therapeutics PTY LTD, headquartered in Sydney, tops this list with the largest team on record.

Which city has the most neuroscience drug developers?

Melbourne leads with 11 headquartered companies, followed by Sydney (5) and Parkville (3).

How do I get contact information for these companies?

A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 126 verified decision-maker contacts tracked across these 34 companies.

How current is this list?

The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 20, 2026.

Ready to reach these companies? Verified emails and direct dials for all 34 neuroscience drug developers based in Australia. Start with a free account, no credit card.

Download this list →

Related lists

About this data

RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.